Application 207264
- Type
- ANDA
- Sponsor
- SAGENT PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIHYDROERGOTAMINE MESYLATE | DIHYDROERGOTAMINE MESYLATE | INJECTABLE;INJECTION | 1MG/ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207264-001 | DIHYDROERGOTAMINE MESYLATE | DIHYDROERGOTAMINE MESYLATE | 1MG/ML | INJECTABLE / INJECTION | AP | 2018-07-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207264-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207264-001 | DIHYDROERGOTAMINE MESYLATE | 1MG/ML | INJECTABLE / INJECTION | AP | 2018-07-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207264-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ATZUMI | DIHYDROERGOTAMINE MESYLATE | Satsuma Pharmaceuticals, Inc. | 0982a44a-dc0c-75c0-e063-6394a90a6d6c | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine Mesylate | DIHYDROERGOTAMINE MESYLATE | Milla Pharmaceuticals Inc. | b464a64d-b150-4f6b-b3df-e486a41294d7 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE |
| DIHYDROERGOTAMINE MESYLATE | DIHYDROERGOTAMINE MESYLATE | Somerset Therapeutics, LLC | c8ffdc19-a90d-453c-b094-2347e116b405 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | DIHYDROERGOTAMINE MESYLATE DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine mesylate | DIHYDROERGOTAMINE MESYLATE | Advagen Pharma Ltd | 65f8c60d-9213-48ac-8233-acc5d44548f4 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine mesylate DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine Mesylate | DIHYDROERGOTAMINE MESYLATE | Hikma Pharmaceuticals USA Inc. | 9ffe6d5a-7348-0498-e053-2a95a90a97a8 | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE |
| BREKIYA | DIHYDROERGOTAMINE MESYLATE | Amneal Pharmaceuticals LLC | cdbf5619-767f-4165-aec2-17bdd92d9ca2 | 2025-10-04 | Boxed warning, Warnings, Adverse reactions | DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine mesylate | DIHYDROERGOTAMINE MESYLATE | Trifluent Pharma, LLC | 4cb78f66-6ccf-4ac7-8599-e199f6995f05 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine mesylate DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine Mesylate | DIHYDROERGOTAMINE MESYLATE | Oceanside Pharmaceuticals | 977de209-c53a-4cb4-9f3f-1e850600a9dc | 2025-03-06 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine Mesylate | DIHYDROERGOTAMINE MESYLATE | Provepharm Inc. | 40b9ba9e-436e-444e-b078-01b12bb57ea7 | 2025-02-25 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE |
| Trudhesa | DIHYDROERGOTAMINE MESYLATE | Impel Pharmaceuticals LLC | b81397b0-910d-4eb4-8fee-a9a3c9d94d63 | 2025-01-17 | Boxed warning, Warnings, Adverse reactions | DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine Mesylate | DIHYDROERGOTAMINE MESYLATE | Hikma Pharmaceuticals USA Inc. | 3fbec3be-9f30-448e-89b9-367a55ed4c97 | 2024-03-15 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine Mesylate | DIHYDROERGOTAMINE MESYLATE | Gland Pharma Limited | 07a9112c-8c04-4849-8cb3-9463f58731d2 | 2023-08-22 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE |
| dihydroergotamine mesylate | DIHYDROERGOTAMINE MESYLATE | Baxter Healthcare Corporation | f87dcd07-90ef-4e37-853e-7a5911a038b1 | 2023-07-14 | Boxed warning, Warnings, Adverse reactions | dihydroergotamine mesylate DIHYDROERGOTAMINE MESYLATE |
| Dihydroergotamine Mesylate | DIHYDROERGOTAMINE MESYLATE | Hikma Pharmaceuticals USA Inc. | 683ca944-efa7-4ca3-9cbe-cf0e7ffb1d64 | 2023-03-17 | Boxed warning, Warnings, Adverse reactions | Dihydroergotamine Mesylate DIHYDROERGOTAMINE MESYLATE |